Pancreatic Cell News 8.29 July 25, 2017 | |
| |
TOP STORYResearchers explored the role of irisin as a new pancreatic beta-cell secretagogue and survival factor, and its potential role in the communication between skeletal muscle and pancreatic beta-cells under lipotoxic conditions. [Diabetes] Abstract | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)DIABETES & PANCREATITISUsing a human islet amyloid polypeptide transgenic mouse model of islet amyloidosis, investigators showed that apoptosis repressor with caspase recruitment domain (ARC) knockdown increases amyloid-induced β-cell apoptosis and loss, while ARC overexpression decreases amyloid-induced apoptosis, thus preserving β cells. [Diabetes] Abstract Scientists reconstructed human fetal pancreatic differentiation using cell surface markers. [Elife] Abstract IKKβ Inhibition Prevents Fat-Induced Beta Cell Dysfunction In Vitro and In Vivo In Rodents It has been shown that oxidative stress plays a causal role in beta cell dysfunction induced by fat. Researchers address whether the proinflammatory kinase inhibitor of (nuclear factor) κB kinase β (IKKβ), which is activated by oxidative stress, is also implicated. [Diabetologia] Abstract Transplantation Sites for Human and Murine Islets In humans, islet transplants are currently infused into the liver via the portal vein, although this site has disadvantages. The authors investigated alternative transplantation sites for human and murine islets in recipient mice, comparing the portal vein with quadriceps muscle and kidney, liver and spleen capsules. [Diabetologia] Full Article 3D Printed Vascularized Device for Subcutaneous Transplantation of Human Islets Scientists present a novel 3D printed and functionalized encapsulation system for subcutaneous engraftment of islets or islet like cells. [Biotechnol J] Abstract PANCREATIC CANCERMUC1-Mediated Metabolic Alterations Regulate Response to Radiotherapy in Pancreatic Cancer Researchers investigated the role of MUC1-mediated metabolism in radiation resistance of pancreatic cancer by utilizing cell lines and in vivo models. MUC1 expression diminished radiation-induced cytotoxicity and DNA damage in pancreatic cancer cells by enhancing glycolysis, pentose phosphate pathway, and nucleotide biosynthesis. [Clin Cancer Res] Abstract Centrosomal Protein 55 Activates NF-κB Signaling and Promotes Pancreatic Cancer Cells Aggressiveness Investigators provide insights into the oncogenic roles of centrosomal protein 55 (CEP55) and the mechanism by which the NF-κB pathway is hyperactivated in patients with pancreatic cancer (PANC). CEP55 overexpression accelerated PANC cells tumorigenicity, together with upregulation of the protein levels of invasion-related proteins matrix metalloproteinase (MMP)2, MMP9, and proliferation-related protein Cyclin D1. [Sci Rep] Full Article Scientists explored decreased tumor suppressor miRNA plasma levels in pancreatic cancer patients to clarify their potential as novel biomarkers and therapeutic targets. [Sci Rep] Full Article Sporamin Induces Apoptosis and Inhibits NF-κB Activation in Human Pancreatic Cancer Cells The authors studied the effects of sporamin on two human pancreatic cancer cell lines, PANC-1 and BxPC-3. Sporamin significantly inhibited the cell viability and proliferation activity and induced apoptosis in PANC-1 and BxPC-3 cells. [Tumor Biol] Full Article | |
| |
REVIEWSThe islet-type ryanodine receptor mRNA is expressed in a variety of tissues such as pancreatic islets, cerebrum, cerebellum, and other neuro-endocrine cells, whereas the authentic type 2 ryanodine receptor mRNA (the heart-type ryanodine receptor) was generated using GG/AG splicing of intron 75 and is expressed in the heart and the blood vessel. [Int J Biochem Cell Biol] Abstract ANGPTL8 (Betatrophin) Role in Diabetes and Metabolic Diseases Researchers highlight some key clinical findings, mainly from human studies, that investigated the role of ANGPTL8 in metabolic diseases such as diabetes, obesity and the metabolic syndrome. [Diabetes Metab Res Rev] Abstract Visit our reviews page to see a complete list of reviews in the pancreatic cell research field. | |
| |
INDUSTRY NEWSSenseonics Holdings, Inc. announced a collaboration with TypeZero Technologies, Inc. and Roche Diabetes Care, Inc. to develop a long-term automated insulin delivery system. [Senseonics Holdings, Inc.] Press Release Merck announced that the U.S. FDA has granted tentative approval for LUSDUNA™ Nexvue™, a follow-on biologic basal insulin in a pre-filled dosing device. [Merck] Press Release | |
| |
POLICY NEWSFrench Funding Agency President Resigns amidst Tensions Michael Matlosz, president and CEO of the French National Research Agency in Paris, resigned following months of controversy over how the agency handles grant proposal evaluations. [ScienceInsider] Editorial Salk Institute Hit with Discrimination Lawsuit by Third Female Scientist Following two gender discrimination lawsuits filed last week, a third senior female professor at the Salk Institute for Biological Studies has similarly sued the storied independent institute in San Diego, California. [ScienceInsider] Editorial
| |
EVENTSNEW Stem Cell Society Singapore’s (SCSS) Symposium 2017 Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESPostdoctoral Researcher – Obesity and Diabetes (University of Iowa) Assistant Professor – Metabolic Disorders (Umeå University) Senior Scientific Officer – Pancreatic Cancer (Cancer Research UK Beatson Institute) Senior/Principal Scientist – Stem Cell Research (Plasticell Ltd) Group Leader – Cancer Research (University of Lille) Postdoctoral Research Fellow – Pancreatic Cancer (Fred Hutchinson Cancer Research Center) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Pancreatic Cell News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|